Bombay Super Hybrid Seeds Board Meeting Outcome

Bombay Super Hybrid Seeds Other Announcement

This filing provides the quarterly shareholding pattern of Bombay Super Hybrid Seeds Ltd for the period ending September 30, 2026. It complies with Regulation 31(1)(b).

Bombay Super Hybrid Seeds Q2 FY27 Results: Net Profit ₹2.4 Cr, Up 9.1% YoY

Bombay Super Hybrid Seeds Ltd reported revenue from operations of ₹85.9 Cr (+220.5% YoY) and net profit of ₹2.4 Cr (+9.1% YoY) for Q2 FY27.

Key figure

Net profit ₹2.4 Cr · +9.1% YoY

Bombay Super Hybrid Seeds Board Meeting Date

Bombay Super Hybrid Seeds Limited will hold a board meeting on October 15, 2026, to consider and approve its standalone unaudited financial results.

Bombay Super Hybrid Seeds Management Change

Bombay Super Hybrid Seeds Limited announced the re-appointment of Mrs. Richa Kaushal Mashru as an Independent Director for a second five-year term, effective October 1, 2026.

Bombay Super Hybrid Seeds Annual General Meeting

Bombay Super Hybrid Seeds Limited filed the proceedings of its 12th Annual General Meeting held on September 30, 2026, covering various agenda items.

Bombay Super Hybrid Seeds Credit Rating

CARE Ratings has downgraded the company's bank facilities to CARE BB+ / CARE A4+ and maintained them under the ISSUER NOT COOPERATING category.

Value

₹125.0 Cr

R R Kabel Board Meeting Outcome

RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.

M K Exim (India) Board Meeting Outcome

M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.

United Spirits Board Meeting Outcome

United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.

SBI Funds Management Board Meeting Outcome

SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.

Execution

April 1, 2028 to March 31, 2030

Paras Healthcare Board Meeting Outcome

Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.

Gateway Distriparks Board Meeting Outcome

Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.